EllenRx® Prior Authorization Card

Rinvoq (upadacitinib)

FDA-approved uses
RA, PsA, Atopic Dermatitis, UC, Crohn's disease, AS, nr-axSpA, JIA, Giant cell arteritis
How it's given
By mouth
Sources checked
2026-11-10

What payers commonly require

  • For arthritis or gut conditions: tried a TNF blockerRinvoq is approved for these conditions after a TNF blocker (like Humira) did not work or was not tolerated, so plans ask for that history. If a TNF blocker is not right for you, plans may accept another treatment for UC or Crohn's.Source: FDA label, Aetna, Cigna
  • For eczema: tried another body-wide treatment firstFor eczema, Rinvoq is meant for people whose eczema was not controlled by other medicines that work through the whole body, such as a biologic shot.Source: FDA label, Aetna, Cigna
  • Prescribed by or with a specialistPlans want a specialist for your condition, such as a joint, skin, allergy, or stomach doctor, to prescribe or advise.Source: Aetna, Cigna
  • Not combined with biologics or strong immune drugsRinvoq should not be used with other biologics, other JAK drugs, or strong immune-lowering drugs, and plans will not pay for that combination.Source: FDA label, Aetna, Cigna
  • TB test before startingRinvoq can wake up a hidden tuberculosis infection, so the label and plans call for a TB test before your first dose.Source: FDA label, Aetna

Each plan has its own policy. Check the patient's plan before submitting.

Letter of medical necessity

Address each item above in the letter and attach the chart notes that show it: the diagnosis, prior treatments with dates and results, and any required test results.

Draft a letter with Ellen

Patients: see the Rinvoq patient page.

Sources: FDA label (DailyMed), Aetna (Policy Rinvoq SGM 3173-A P2026a, page dated June 14, 2026), Cigna (Effective 06/01/2026).

Not medical advice. For educational use by clinic staff. Ellen does not diagnose conditions or recommend treatments. Payer policies change often; confirm with the patient's plan.